Cleared Traditional

K031641 - VASCULAR ARCHITECTS ASPIRE COVERED STEN...

K031641 is an FDA 510(k) clearance for VASCULAR ARCHITECTS ASPIRE COVERED STEN..., manufactured by Vascular Architects, Inc.. The device is a Class 2 General & Plastic Surgery device with product code JCT cleared through the Traditional 510(k) pathway after a 66-day FDA review.

K031641 · Vascular Architects, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2003
Decision
66d
Days
Class 2
Risk

K031641 is an FDA 510(k) clearance for the VASCULAR ARCHITECTS ASPIRE COVERED STENT AND 718 DELIVERY SYSTEM. Classified as Prosthesis, Tracheal, Expandable (product code JCT), Class II - Special Controls.

Submitted by Vascular Architects, Inc. (San Jose, US). The FDA issued a Cleared decision on August 1, 2003 after a review of 66 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.3720 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Vascular Architects, Inc. devices

FDA 510(k) Submission Details - K031641

510(k) Number K031641 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 27, 2003
Decision Date August 01, 2003
Days to Decision 66 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 115d · This submission: 66d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JCT Device Classification - Class 2, Special Controls

Product Code JCT Prosthesis, Tracheal, Expandable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.3720
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - JCT Prosthesis, Tracheal, Expandable

All 30
Devices cleared under the same product code (JCT) and FDA review panel - the closest regulatory comparables to K031641.
FLUENCY PLUS TRACHEOBRONCHIAL STENT GRAFT
K050832 · Bard Peripheral Vascular, Inc. · Jul 2005
ATRIUM ICAST COVERED STENT
K050814 · Atrium Medical Corp. · May 2005
ATRIUM MEDICAL CORPORATION ICAST COVERED STENT
K041269 · Atrium Medical Corp. · Sep 2004
VIATORR ENDOPROSTHESIS
K024178 · W.L. Gore & Associates, Inc. · Mar 2003
MODIFICATION TO VIABAHN ENDOPROSTHESIS
K023811 · W.L. Gore & Associates, Inc. · Dec 2002
WALLGRAFT TRACHEOBRONCHIAL ENDOPROTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
K021901 · Boston Scientific Scimed, Inc. · Jul 2002